Clinical application of quantitative 99mTc-HYNIC-PSMA SPECT/CT in prostate cancer

被引：0
|
作者：
Gao, Y. [1 ]
Shi, J. [1 ]
机构：
[1] Zhengzhou Univ, Dept Nucl Med, Peoples Hosp, Henan Prov Peoples Hospital
来源：
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING | 2022年 / 49卷 / SUPPL 1期
关键词：
D O I：
暂无
中图分类号：
R8 [特种医学]; R445 [影像诊断学];
学科分类号：
1002 ; 100207 ; 1009 ;
摘要：
190
引用
收藏
页码：S503 / S504
页数：2
相关论文
共 50 条
  • [41] Clinical translation of a PSMA inhibitor for 99mTc-based SPECT
    Ferro-Flores, Guillermina
    Luna-Gutierrez, Myrna
    Ocampo-Garcia, Blanca
    Santos-Cuevas, Clara
    Azorin-Vega, Erika
    Jimenez-Mancilla, Nallely
    Orocio-Rodriguez, Emmanuel
    Davanzo, Jenny
    Garcia-Perez, Francisco O.
    NUCLEAR MEDICINE AND BIOLOGY, 2017, 48 : 36 - 44
  • [42] Comparison of 99mTc-PSMA SPECT/CT and 68Ga-PSMA PET/CT in patients with prostate cancer: a protocol for systematic review and meta-analysis
    Yunusa, Garba Haruna
    Kaoje, Aminu Umar
    Orunmuyi, Akintunde Taiwo
    More, Stuart S.
    Jawa, Zabah Muhammad
    Khalid, Abdullahi
    EGYPTIAN JOURNAL OF RADIOLOGY AND NUCLEAR MEDICINE, 2021, 52 (01):
  • [43] Comparison of 99mTc-PSMA SPECT/CT and 68Ga-PSMA PET/CT in patients with prostate cancer: a protocol for systematic review and meta-analysis
    Garba Haruna Yunusa
    Aminu Umar Kaoje
    Akintunde Taiwo Orunmuyi
    Stuart S. More
    Zabah Muhammad Jawa
    Abdullahi Khalid
    Egyptian Journal of Radiology and Nuclear Medicine, 52
  • [44] THE VALUE OF 99MTC-PSMA SPECT/CT GUIDED SURGERY TO IDENTIFY AND LOCALIZE LYMPH NODE METASTASIS FOR PROSTATE CANCER PATIENTS
    Su, Hengchuan
    JOURNAL OF UROLOGY, 2018, 199 (04): : E567 - E568
  • [45] Diagnostic value of [99mTc]Tc-PSMA-I&S-SPECT/CT for the primary staging and restaging of prostate cancer
    Farkas, Istvan
    Sipka, Gabor
    Bakos, Annamaria
    Maraz, Aniko
    Bajory, Zoltan
    Miko, Zsofia
    Czekus, Tamas
    Urban, Szabolcs
    Varga, Linda
    Pavics, Laszlo
    Besenyi, Zsuzsanna
    THERAPEUTIC ADVANCES IN MEDICAL ONCOLOGY, 2024, 16
  • [46] SPECT/CT With the PSMA Ligand 99mTc-MIP-1404 for Whole-Body Primary Staging of Patients With Prostate Cancer
    Schmidkonz, Christian
    Cordes, Michael
    Beck, Michael
    Goetz, Theresa Ida
    Schmidt, Daniela
    Prante, Olaf
    Baeuerle, Tobias
    Uder, Michael
    Wullich, Bernd
    Goebell, Peter
    Kuwert, Torsten
    Ritt, Philipp
    CLINICAL NUCLEAR MEDICINE, 2018, 43 (04) : 225 - 231
  • [47] SPECT/CT with the PSMA Ligand 99mTc-MIP-1404 for Whole-Body Primary Staging of Patients with Prostate Cancer
    Schmidkonz, Christian
    Cordes, Michael
    Beck, Michael
    Goetz, Theresa
    Schmidt, Daniela
    Prante, Olaf
    Bauerle, Tobias
    Uder, Michael
    Wullich, Bernd
    Goebell, Peter
    Kuwert, Torsten
    Ritt, Philipp
    JOURNAL OF NUCLEAR MEDICINE, 2018, 59
  • [48] Comparison of 99Tcm-PSMA SPECT/CT and 99Tcm-MDP SPECT/CT in the diagnosis of Bone Metastasis of Prostate Cancer
    Zhang, Yu
    Chen, WenXin
    Su, YaoDong
    JOURNAL OF NUCLEAR MEDICINE, 2021, 62
  • [49] Comparing the role of 99mTc-HYNIC-PSMA-11 and 99mTc-MDP scintigraphy for the initial staging of intermediate to high-risk prostate cancer
    Ghaedian, Tahereh
    Abdinejad, Maryam
    Nasrollahi, Hamid
    Ghaedian, Mehrnaz
    Firuzyar, Tahereh
    NUCLEAR MEDICINE COMMUNICATIONS, 2023, 44 (10) : 864 - 869
  • [50] Head-to-head comparison of 99mTc-PSMA and 99mTc-MDP SPECT/CT in diagnosing prostate cancer bone metastasis: a prospective, comparative imaging trial
    Zhang, Yu
    Lin, Zhiyi
    Li, Tao
    Wei, Yongbao
    Yu, Mingdian
    Ye, Liefu
    Cai, Yuqing
    Yang, Shengping
    Zhang, Yanmin
    Shi, Yuanying
    Chen, Wenxin
    SCIENTIFIC REPORTS, 2022, 12 (01)
12345